ClariVest Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

ClariVest Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-19,681	Closed	-$1.25M	–	624
2015 Q1	$1.25M	Sell	19,681 -185	-0.9%	-$12.6K	0.04%	265
2014 Q4	$1.23M	Buy	19,866 +5,739	+41%	+$283K	0.04%	210
2014 Q3	$549K	Sell	14,127 -13	-0.1%	-$461	0.02%	266
2014 Q2	$487K	Buy	14,140 +18	+0.1%	+$567	0.02%	279
2014 Q1	$611K	Buy	+14,122	New	+$685K	0.02%	254

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

ClariVest Asset Management's IONS Position: Q2 2015 in Review

ClariVest Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2015, closing a stake of 19,681 shares — an estimated $1.25M sold.

ClariVest Asset Management first reported a position in IONS in Q1 2014 and held it in 5 quarters. The position peaked at $1.25M in Q1 2015. 353 funds tracked by Wall St. Rank hold IONS as of Q2 2015.

ClariVest Asset Management reported no remaining Ionis Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
ClariVest Asset Management sold 19,681 Ionis Pharmaceuticals shares in Q2 2015, an estimated $1.25M.
ClariVest Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 5 quarters.
ClariVest Asset Management's Ionis Pharmaceuticals position peaked at $1.25M in Q1 2015.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2015.

Based on ClariVest Asset Management's 13F filing for Q2 2015, filed 27 Jul 2015.